See What’s Possible in Life Sciences Packaging @ PACK EXPO International
2,600 exhibitors. 150+ free educational sessions. See packaging solutions for life sciences & more @ PACK EXPO International, Oct 18-21 in Chicago
REGISTER NOW & SAVE

Create a free Healthcare Packaging account to continue reading

Constantia Flexibles successfully reprices Term Loan B

Constantia Flexibles Group (“Constantia Flexibles” or the“Company”) today successfully accomplished the repricing, amendment and upsizing of its covenant-lite cross-border Term Loan B facility (the “Term Loan”).

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

Constantia Flexibles Group (“Constantia Flexibles” or the“Company”) today successfully accomplished the repricing, amendment and upsizing of its covenant-lite cross-border Term Loan B facility (the “Term Loan”).

As part of the transaction, Constantia Flexibles made certain amendments to its €1.2bn syndicated loan facilities to improve operational flexibility, and reduced the margin on its €660mm EUR Term Loan to Euribor + 300 bps (from Euribor + 375 bps).

The US Dollar Tranche was successfully upsized to $250mm, with the aim to create a more liquid US Dollar facility backed by a broader investor base in order to further enhance global capital market access. The US Dollar Tranche was repriced to Libor + 300 bps (from Libor + 375 bps).

Supported by a strong interest from investors, both the Euro and US Dollar tranches were substantially oversubscribed, which is a reflection of Constantia Flexibles’ strong operational performance and reputation among existing and new investors.

Stephan Kuehne, Chief Financial Officer, commented: “The success of the transaction demonstrates the strong support Constantia Flexibles gets from the capital market, which buys into its proven global growth story”.
The transaction was arranged by J.P. Morgan, UniCredit and Bank of America Merrill Lynch.

Closing of the transaction is expected on September 30, 2016.
The facility is rated B/B1, while the company is rated B+/B1 by Standard & Poor’s and Moody’s, respectively.

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026
See What’s Possible in Life Sciences Packaging at PACK EXPO International
Explore new machinery & materials from 2,600 exhibitors. Gain insights from 150+ free educational sessions. Find solutions to tackle the toughest challenges—for life sciences & beyond—at North America’s largest packaging & processing event.
REGISTER NOW & SAVE
See What’s Possible in Life Sciences Packaging at PACK EXPO International